早期的多疗法可能是对子胺耐药的先天性状态 (第一阶段加上)
1Department of Neuroscience, "Giovanni Paolo II" Hospital, Lamezia Terme, 88046 Catanzaro, Italy.
Neurology international
|January 24, 2025
概括
第1阶段Plus状态 (SE) 涉及可能对类药物 (BDZ) 耐药的未经治疗的患者. 这种情况可能需要从组合多疗法开始,以获得更好的结果.
科学领域:
- 神经学 神经学
- 发病学 (Epileptology) 是一个专业的学科.
背景情况:
- 状态 (SE) 是一种医疗紧急情况.
- 抗代谢 (BDZ) 耐药性是SE管理中的一个重大挑战.
- 确定早期对BDZ耐火的SE对于及时干预至关重要.
研究的目的:
- 为了定义"第一阶段加"的SE:未接受过治疗的SE可能是BDZ的耐火性.
- 审查病理生理学和临床前证据,支持1阶段加SE.新的治疗方法.
- 从第一阶段加SE开始倡导组合多疗法.
主要方法:
- 对病理生理机制的审查.
- 分析临床前数据,主要来自动物模型.
- 关于SE特征和BDZ折射率的文献综述.
主要成果:
- 第1阶段加SE包括长期SE (>10分钟) 和细微运动征兆或急性病因病例.
- 缺少突出的运动现象 (例如,非性SE) 可能导致识别和治疗延迟.
- 需要针对延长性SE的病因学具体定义.
结论:
- 阶段1+SE是SE的一个明显的早期阶段,需要量身定制的治疗策略.
- 在发病时开始的组合多疗法可能比第一阶段加SE的顺序治疗更有效.
- 需要进一步的研究来完善第一阶段加SE的定义和治疗方案.
相关概念视频
Antiepileptic Drugs: GABAergic Pathway Potentiators
316
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
316
Antiepileptic Drugs: Potassium Channel Activators
142
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
142
Sedatives and Hypnotics Drugs: Benzodiazepines
180
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
180
Anxiolytic Drugs: Benzodiazepines and Buspirone
492
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
492
CNS Depressants: Barbiturates and Benzodiazepines
216
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
216
Antiepileptic Drugs: Glutamate Antagonists
273
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
273


